Heart Test Operating Margin Over Time
| HSCSW Stock | USD 0.10 0.01 9.09% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Heart Test Performance and Heart Test Correlation. What growth prospects exist in Health Care Equipment & Supplies sector? Can Heart capture new markets? Factors like these will boost the valuation of Heart Test. Market participants price Heart higher when confident in its future expansion prospects. Valuation analysis balances hard financial data with qualitative growth assessments. While each Heart Test valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 6.538 | Return On Assets | Return On Equity |
Investors evaluate Heart Test Laboratories using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Heart Test's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. External factors like market trends, sector rotation, and investor psychology can cause Heart Test's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Heart Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heart Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Heart Test's market price signifies the transaction level at which participants voluntarily complete trades.
Cross Equities Operating Profit Margin Analysis
Compare Heart Test Laboratories and related stocks such as Bone Biologics Corp, Venus Concept, and NanoVibronix Operating Margin Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBLG | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| VERO | (1.1912) | (1.1912) | (1.1912) | (1.1912) | (1.1912) | (1.1912) | (1.2136) | (0.8115) | (1.1799) | (0.2742) | (0.8703) | (0.1398) | (0.3505) | (0.3708) | (0.4193) | (0.38) | (0.4) |
| SHPH | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| DHAI | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2217) | (0.2133) | (0.004) | (0.0405) | (0.0774) | (0.0696) | (0.0731) |
| VTAK | (0.7025) | (0.7025) | (0.7025) | (0.7025) | (0.7025) | (0.7025) | (0.7025) | (3.0256) | (4.98) | (8.0192) | (137) | (1.3 K) | (1.9 K) | (177) | (26.769) | (30.78) | (32.32) |
| MOVE | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (23.9112) | (21.52) | (22.6) |
| BJDX | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (37.4148) | (33.67) | (35.36) |
| GCTK | 60.349 | 60.349 | 60.349 | 60.349 | 60.349 | 32.5169 | 9.2463 | 17.9415 | 150 | 16.8558 | 16.8558 | 16.8558 | 16.8558 | 16.8558 | 16.8558 | 15.17 | 14.41 |
| NDRA | (2.7285) | (2.7285) | (2.7285) | (2.7285) | (2.7285) | (1.1124) | (3.4752) | (13.1563) | (1.5 K) | (1.5 K) | (1.5 K) | (1.5 K) | (1.5 K) | (1.5 K) | (1.5 K) | (1.7 K) | (1.6 K) |
Heart Test Laboratories and related stocks such as Bone Biologics Corp, Venus Concept, and NanoVibronix Operating Profit Margin description
My Equities
My Current Equities and Potential Positions
| Heart Test Laboratories | HSCSW |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 550 Reserve Street, |
| Exchange | NASDAQ Exchange |
USD 0.1
Additional Tools for Heart Stock Analysis
When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.